Teva Hit With Securities Class Action Over CEO Resignation
By Kat Greene ( December 18, 2013, 10:12 PM EST) -- Teva Pharmaceutical Industries Inc. was slapped with a putative class action in New York federal court on Wednesday when a shareholder alleged the company intentionally misled the media and investors about a dispute between the CEO and the board of directors....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.